NEXMED

Health articles

What the evidence shows about GLP-1 weight-loss treatments (Wegovy, Mounjaro, Ozempic, Saxenda) and about perimenopause, menopause, HRT and hot flashes.

14 November 2026

Hot Flashes and Night Sweats: Causes, How Long They Last and Treatment Options

Why menopausal hot flashes and night sweats happen, how long they usually last, and which treatments have good evidence, with and without hormones.

14 November 2026

HRT Benefits and Risks: Is Hormone Therapy Safe? What the Numbers Show

Is HRT safe? The benefits and risks of menopausal hormone therapy in absolute numbers per 1,000 women, from NICE and the WHI trials.

14 November 2026

Menopause Symptoms, Average Age and Diagnosis: What to Expect

Menopause is confirmed after 12 months without a period, usually around age 51. What the symptoms are, how it is diagnosed, how long it lasts and why early menopause needs attention.

14 November 2026

Perimenopause Symptoms, Age and How Long It Lasts: A Clear Guide

Perimenopause can start in your late 30s or 40s and last several years. The first signs, irregular periods, when tests help, pregnancy risk and treatment options, explained with NICE and NHS guidance.

14 November 2026

Types of HRT: Patch, Gel or Tablets, Progesterone and How Treatment Works

HRT is not one medicine but a set of choices: which estrogen, which route, which progestogen and which regimen. Here is how the options differ and what the first months of treatment usually look like.

1 October 2026

The Wegovy pill after injections: what the OCTANE study shows

Patients who switched from injections to the Wegovy pill kept losing weight. What the study actually shows, and what it means for you.

30 September 2026

The Minimum Effective GLP-1 Dose: Do You Need the Maximum Dose?

Not everyone needs the maximum GLP-1 dose. What trials show about lower doses and what the official prescribing information allows.

30 September 2026

Mounjaro 5 mg vs 10 mg vs 15 mg: what the trials show

SURMOUNT-1 results for each Mounjaro dose: weight loss, side effects and what it means for you.

30 September 2026

Lowering the dose after weight loss: what the SURMOUNT-MAINTAIN trial shows

The first large trial on lowering the dose after weight loss: what happens on the full dose, on 5 mg and after stopping treatment.

30 September 2026

GLP-1 Microdosing (Ozempic, Mounjaro): What's Real and What's Marketing

GLP-1 microdosing is a trend with no studies behind it. What's real, what the risks are, and what safe alternative exists.

30 September 2026

Ozempic overdose: why it isn't safe to calculate your own dose

Hand-measured doses have led to real overdoses. Why the errors happen, what the FDA reported and the signs that mean you should call your doctor.

30 September 2026

Reducing your GLP-1 dose: how to talk to your doctor

Legitimate reasons for a lower dose, what to prepare before your appointment and the questions to ask your doctor.

11 September 2026

GLP-1 and Addiction: Can They Reduce Cravings for Alcohol and Cigarettes?

Do GLP-1 medications reduce cravings for alcohol and cigarettes? What studies show (especially for alcohol), the mechanism, and the essential caveats.

8 September 2026

The future of GLP-1: pills and the next generation of medicines

GLP-1 pills are now a reality: the Wegovy pill is approved in the EU, orforglipron in the US. What's approved, what's coming next and what it means for you.

8 September 2026

Sleep Apnea and GLP-1 Medications: The Link With Weight

Sleep apnea is serious and closely tied to weight. How standard treatment (CPAP) and the new GLP-1/GIP medications complement each other.

7 September 2026

GLP-1 and Fertility: The "Ozempic Babies" Phenomenon, Explained

Why unexpected pregnancies occur in women taking GLP-1 medications, the link with PCOS, and why these drugs are not taken during pregnancy.

26 August 2026

GLP-1 and the Heart/Kidneys: Benefits Beyond Weight Loss

GLP-1 medications don't just help you lose weight: trials show benefits for the heart and kidneys. What the data say and who they're for.

19 August 2026

Mounjaro vs Wegovy: differences, results and how to choose (2026 guide)

A complete Mounjaro vs Wegovy comparison: mechanism, trial results, dose escalation, side effects, cost and how to choose between them.

19 August 2026

Wegovy and Mounjaro Side Effects: What to Know and How to Manage Them

An in-depth guide to Wegovy and Mounjaro side effects: the common (digestive) ones, the rare ones, how to reduce them, and when to contact your doctor.